Journal Article
A. Baird, Brancatisano, O., Gelding, R., and Thompson, W. Forde,
“Characterization of Music and Photograph Evoked Autobiographical Memories in People with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 693-706, 2018.
S. E. O'Bryant, Petersen, M., Hall, J., Johnson, L. A., Barber, R., Phillips, N., Braskie, M. N., Yaffe, K., Rissman, R., and Toga, A.,
“Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.”,
J Alzheimers Dis, vol. 90, no. 2, pp. 905-915, 2022.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C.,
“Characterization of Amyloid-β Deposits in Bovine Brains.”,
J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C.,
“Characterization of Amyloid-β Deposits in Bovine Brains.”,
J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E.,
“Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
C. Akiba, Nakajima, M., Miyajima, M., Ogino, I., Motoi, Y., Kawamura, K., Adachi, S., Kondo, A., Sugano, H., Tokuda, T., Irie, K., and Arai, H.,
“Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.”,
J Alzheimers Dis, vol. 63, no. 3, pp. 989-1002, 2018.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q.,
“Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”,
J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M.,
“Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.”,
J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M.,
“Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.”,
J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H.,
“Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
S. Lista, Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., Cavedo, E., Santos, A. Melo Dos, Epelbaum, S., Lamari, F., Dubois, B., Nisticò, R., Floris, R., Garaci, F., and Hampel, H.,
“Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1327-1334, 2017.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E.,
“Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.”,
J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
N. P. Rocha, Toledo, A., Corgosinho, L. T. S., de Souza, L. C., Guimarães, H. C., Resende, E. P. F., Braz, N. F. T., Gomes, K. B., Silva, A. C. Simoes E., Caramelli, P., and Teixeira, A. L.,
“Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
N. P. Rocha, Toledo, A., Corgosinho, L. T. S., de Souza, L. C., Guimarães, H. C., Resende, E. P. F., Braz, N. F. T., Gomes, K. B., Silva, A. C. Simoes E., Caramelli, P., and Teixeira, A. L.,
“Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
L. Calderón-Garcidueñas, Avila-Ramírez, J., Calderón-Garcidueñas, A., González-Heredia, T., Acuña-Ayala, H., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Cortés-González, V., Martínez-Martínez, L., García-Pérez, M. Alberto, Reis, J., Mukherjee, P. S., Torres-Jardón, R., and Lachmann, I.,
“Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 597-613, 2016.
L. Calderón-Garcidueñas, Avila-Ramírez, J., Calderón-Garcidueñas, A., González-Heredia, T., Acuña-Ayala, H., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Cortés-González, V., Martínez-Martínez, L., García-Pérez, M. Alberto, Reis, J., Mukherjee, P. S., Torres-Jardón, R., and Lachmann, I.,
“Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 597-613, 2016.
D. Renard, Gabelle, A., Hirtz, C., Demattei, C., Thouvenot, E., and Lehmann, S.,
“Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.”,
J Alzheimers Dis, vol. 54, no. 4, pp. 1291-1295, 2016.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S.,
“Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.”,
J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
I. van Steenoven, Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L., and Lemstra, A. W.,
“Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 287-95, 2016.
J. J. Claus, Coenen, M., Staekenborg, S. S., Schuur, J., Tielkes, C. E. M., Koster, P., and Scheltens, P.,
“Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.”,
J Alzheimers Dis, 2018.
Y. Hatada, Hashimoto, M., Shiraishi, S., Ishikawa, T., Fukuhara, R., Yuki, S., Tanaka, H., Miyagawa, Y., Kitajima, M., Uetani, H., Tsunoda, N., Koyama, A., and Ikeda, M.,
“Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
Y. Hatada, Hashimoto, M., Shiraishi, S., Ishikawa, T., Fukuhara, R., Yuki, S., Tanaka, H., Miyagawa, Y., Kitajima, M., Uetani, H., Tsunoda, N., Koyama, A., and Ikeda, M.,
“Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
S. L. Gardener, Sohrabi, H. R., Shen, K. - K., Rainey-Smith, S. R., Weinborn, M., Bates, K. A., Shah, T., Foster, J. K., Lenzo, N., Salvado, O., Laske, C., Laws, S. M., Taddei, K., Verdile, G., and Martins, R. N.,
“Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.”,
J Alzheimers Dis, vol. 52, no. 2, pp. 661-72, 2016.
D. Renard, Tatu, L., Collombier, L., Wacongne, A., Ayrignac, X., Charif, M., Boukriche, Y., Chiper, L., Fourcade, G., Azakri, S., Gaillard, N., Mercier, E., Lehmann, S., and Thouvenot, E.,
“Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1113-1121, 2018.
D. Renard, Tatu, L., Collombier, L., Wacongne, A., Ayrignac, X., Charif, M., Boukriche, Y., Chiper, L., Fourcade, G., Azakri, S., Gaillard, N., Mercier, E., Lehmann, S., and Thouvenot, E.,
“Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1113-1121, 2018.
] Year 